Healthcare provider profile · identity verified

Hsin-Yi Wang, MD

Family Practice · LYNNWOOD, WA · NPI 1245523695

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	321	88
Lisinopril	Lisinopril	218	67
Losartan Potassium	Losartan Potassium	183	54
Amlodipine Besylate	Amlodipine Besylate	148	46
Trazodone Hcl	Trazodone Hcl	125	38
Levothyroxine Sodium	Levothyroxine Sodium	113	34
Omeprazole	Omeprazole	99	32
Ondansetron Hcl	Ondansetron Hcl	95	suppressed
Metformin Hcl	Metformin Hcl	88	32
Rosuvastatin Calcium	Rosuvastatin Calcium	79	23
Gabapentin	Gabapentin	78	29
Sertraline Hcl	Sertraline Hcl	76	27
Simvastatin	Simvastatin	71	19
Metoprolol Succinate	Metoprolol Succinate	69	23
Metformin Hcl Er	Metformin Hcl	62	19
Atenolol	Atenolol	61	18
Jardiance	Empagliflozin	58	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	12
Mirtazapine	Mirtazapine	51	21
Pantoprazole Sodium	Pantoprazole Sodium	50	16
Furosemide	Furosemide	45	11
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Albuterol Sulfate Hfa	Albuterol Sulfate	42	21
Hydrochlorothiazide	Hydrochlorothiazide	41	16
Alendronate Sodium	Alendronate Sodium	37	19
Citalopram Hbr	Citalopram Hydrobromide	36	13
Escitalopram Oxalate	Escitalopram Oxalate	36	15
Famotidine	Famotidine	36	13
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Meloxicam	Meloxicam	33	15
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	33	17
Potassium Chloride	Potassium Chloride	32	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	14
Glipizide	Glipizide	30	11
Memantine Hcl	Memantine Hcl	28	16
Allopurinol	Allopurinol	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	11
Alvesco	Ciclesonide	25	suppressed
Bupropion Xl	Bupropion Hcl	25	14
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Breyna	Budesonide/Formoterol Fumarate	23	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	23	suppressed
Humulin N	Insulin Nph Human Isophane	22	suppressed
Prazosin Hcl	Prazosin Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Estradiol	Estradiol	20	suppressed
Ozempic	Semaglutide	20	suppressed
Finasteride	Finasteride	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Donepezil Hcl	Donepezil Hcl	18	11
Propranolol Hcl	Propranolol Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Yuvafem	Estradiol	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Aripiprazole	Aripiprazole	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error